Crossref
Is it Time to Relook the Management of Axilla in Post-Neoadjuvant Breast Cancer Cases in a Re-Evolving Era of Current Axillary Management?
Breast Cancer Management · 2017
DOI: 10.2217/bmt-2017-0003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer Management, 2017. Verfasst von Shaukat Mahmood Mirza und 4 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mirza, S. M., Ali, L., Rajinder, D., Asad, M., & Aitken, J. (2017). Is it Time to Relook the Management of Axilla in Post-Neoadjuvant Breast Cancer Cases in a Re-Evolving Era of Current Axillary Management?. Breast Cancer Management. https://doi.org/10.2217/bmt-2017-0003
Vancouver
Mirza SM, Ali L, Rajinder D, Asad M, Aitken J. Is it Time to Relook the Management of Axilla in Post-Neoadjuvant Breast Cancer Cases in a Re-Evolving Era of Current Axillary Management?. Breast Cancer Management. 2017. doi:10.2217/bmt-2017-0003
BibTeX
@article{Mirza2017,
author = {Mirza, Shaukat Mahmood and Ali, Liaqat and Rajinder, Dhaliwal and Asad, Maria and Aitken, Jane},
title = {Is it Time to Relook the Management of Axilla in Post-Neoadjuvant Breast Cancer Cases in a Re-Evolving Era of Current Axillary Management?},
journal = {Breast Cancer Management},
year = {2017},
doi = {10.2217/bmt-2017-0003}
}
EUVIMED